AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Locomet G 0.5mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Locus Pharma Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Locomet G 0.5mg/500mg Tablet SR

Diabetic patients using the extended-release combination medication, Locomet G 0.5mg/500mg, benefit from its dual-action approach to managing type 2 diabetes mellitus in adults. This medication effectively regulates blood glucose levels. Consistent daily ingestion, always with food, at the same time each day, maximizes therapeutic effects. Dosage is personalized and adjusted by your physician based on your blood sugar readings. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially causing complications including renal failure, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, requiring adherence to a doctor-recommended diet, regular physical activity, and weight management. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headaches, and tremors. Maintain regular meal schedules, carry a quick-acting glucose source (e.g., juice or candy), and avoid alcohol consumption to mitigate this risk. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions require physician consultation before commencing treatment. Pregnant or lactating individuals should seek medical advice. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are essential under your doctor's care.

Primary Ingredients of Locomet G 0.5mg/500mg Tablet SR

The provided text is "undefined," which lacks meaning and cannot be rephrased. Therefore, no rewritten text is possible.

Uses of Locomet G 0.5mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Locomet G 0.5mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Locomet G 0.5mg/500mg Sustained-Release tablets with food.

Common Side effects of Locomet G 0.5mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Locomet G 0.5mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Locomet G 0.5mg/500mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

How Locomet G 0.5mg/500mg Tablet SR works:

Locomet G 0.5mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Locomet G 0.5mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Prolonged-release Locomet G 0.5mg/500mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Locomet G 0.5mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Locomet G 0.5mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Locomet G 0.5mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Locomet G 0.5mg/500mg SR tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. In individuals with mild to moderate hepatic dysfunction, treatment typically begins with a reduced Locomet G 0.5mg/500mg SR tablet dose; it's contraindicated in those with severe liver disease.

What if you forget to take Locomet G 0.5mg/500mg Tablet SR :

Should you forget a Locomet G 0.5mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Locomet G 0.5mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Locomet G 0.5mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Locomet G 0.5mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Locomet G 0.5mg/500mg Tablet SR and seek immediate medical attention.
Locomet G 0.5mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Locomet G 0.5mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Locomet G 0.5mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Locomet G 0.5mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Locomet G 0.5mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Locomet G 0.5mg/500mg Tab...
41
MRP 47
12% off